Display Settings:

Format

Send to:

Choose Destination
    Neurology. 2001 Jul 24;57(2):321-4.

    Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies.

    Source

    Israeli Teratogen Information Service, Laboratory of Teratology, Jerusalem, Israel.

    Abstract

    The Israeli Teratogen Information Service prospectively followed up 210 pregnancies with first trimester carbamazepine exposure. Pregnancy outcome was compared with that of two overlapping controls, matched and general (n = 629), exposed to nonteratogenic agents. Our study suggests a twofold increase in the rate of major congenital anomalies (12/160 [carbamazepine] versus 18/560 [general control]; relative risk 2.24; 95% CI 1.1-4.56) and a birth weight reduction of approximately 250 g after in utero exposure to carbamazepine.

    PMID:
    11468320
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk